148 related articles for article (PubMed ID: 35312784)
1. Effectiveness and safety of pneumocystis pneumonia prophylaxis for patients receiving temozolomide chemoradiotherapy.
Climans SA; Grunfeld E; Mason WP; Chan KKW
Neuro Oncol; 2022 Oct; 24(10):1738-1748. PubMed ID: 35312784
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of glioma patients who develop pneumocystis pneumonia with temozolomide chemoradiotherapy.
Climans SA; Mason WP; Grunfeld E; Chan K
J Neurooncol; 2022 Sep; 159(3):665-674. PubMed ID: 35932358
[TBL] [Abstract][Full Text] [Related]
3. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole.
Park JW; Curtis JR; Kim MJ; Lee H; Song YW; Lee EB
Arthritis Res Ther; 2019 Sep; 21(1):207. PubMed ID: 31521185
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.
Green H; Paul M; Vidal L; Leibovici L
Cochrane Database Syst Rev; 2007 Jul; (3):CD005590. PubMed ID: 17636808
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of trimethoprim-sulfamethoxazole versus atovaquone for the prophylaxis of pneumocystis pneumonia in patients with connective tissue diseases receiving prolonged high-dose glucocorticoids.
Jinno S; Akashi K; Onishi A; Nose Y; Yamashita M; Saegusa J
Rheumatol Int; 2022 Aug; 42(8):1403-1409. PubMed ID: 34263352
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study.
Yamashita K; Shimomura Y; Ikesue H; Muroi N; Yoshimoto A; Hashida T
BMC Infect Dis; 2021 Jul; 21(1):664. PubMed ID: 34238239
[TBL] [Abstract][Full Text] [Related]
7. Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis.
Jiang X; Mei X; Feng D; Wang X
PLoS One; 2015; 10(4):e0122171. PubMed ID: 25909634
[TBL] [Abstract][Full Text] [Related]
8. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of reduced-dose sulfamethoxazole-trimethoprim for chemoprophylaxis of
Harada T; Kato R; Sueda Y; Funaki Y; Takata M; Okazaki R; Hasegawa Y; Yamasaki A
Mod Rheumatol; 2021 May; 31(3):629-635. PubMed ID: 32820678
[TBL] [Abstract][Full Text] [Related]
10. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
11. Single-day trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis pneumonia in children with cancer.
Caselli D; Petris MG; Rondelli R; Carraro F; Colombini A; Muggeo P; Ziino O; Melchionda F; Russo G; Pierani P; Soncini E; DeSantis R; Zanazzo G; Barone A; Cesaro S; Cellini M; Mura R; Milano GM; Meazza C; Cicalese MP; Tropia S; De Masi S; Castagnola E; Aricò M;
J Pediatr; 2014 Feb; 164(2):389-92.e1. PubMed ID: 24252793
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic effect of trimethoprim-sulfamethoxazole for pneumocystis pneumonia in patients with rheumatic diseases exposed to prolonged high-dose glucocorticoids.
Park JW; Curtis JR; Moon J; Song YW; Kim S; Lee EB
Ann Rheum Dis; 2018 May; 77(5):644-649. PubMed ID: 29092853
[TBL] [Abstract][Full Text] [Related]
13. Impact of Increased Duration of Trimethoprim-Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia After Renal Transplant.
Chapman FA; Dickerson JE; Daly C; Clancy M; Geddes C
Ann Transplant; 2019 Dec; 24():625-630. PubMed ID: 31806862
[TBL] [Abstract][Full Text] [Related]
14. Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole.
Beumont MG; Graziani A; Ubel PA; MacGregor RR
Am J Med; 1996 Jun; 100(6):611-6. PubMed ID: 8678080
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis against pneumocystis pneumonia in rheumatoid arthritis patients treated with b/tsDMARDs: insights from 3787 cases in the FIRST registry.
Sonomoto K; Tanaka H; Nguyen TM; Yoshinari H; Nakano K; Nakayamada S; Tanaka Y
Rheumatology (Oxford); 2022 May; 61(5):1831-1840. PubMed ID: 34382090
[TBL] [Abstract][Full Text] [Related]
17. Sulfamethoxazole-trimethoprim for pneumocystis pneumonia prophylaxis, causes of discontinuation and thrombocytopenia observed during administration: A single-center retrospective study.
Hashimoto M; Hiraiwa M; Uchitani K; Ueda M; Tanaka M; Nishiyama N; Miyashita N
J Infect Chemother; 2024 Feb; 30(2):141-146. PubMed ID: 37797822
[TBL] [Abstract][Full Text] [Related]
18. Higher risk of urinary tract infections in renal transplant recipients receiving pentamidine versus trimethoprim-sulfamethoxazole (TMP-SMX) for Pneumocystis pneumonia prophylaxis.
Fu W; Barahona M; Harkness T; Cohen E; Reardon D; Yoo PS
Clin Transplant; 2020 Nov; 34(11):e14067. PubMed ID: 32810885
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.
Awad WB; Asaad A; Al-Yasein N; Najjar R
BMC Infect Dis; 2020 Jun; 20(1):400. PubMed ID: 32503449
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis in the era of prophylaxis: do the guidelines have to change?
Nunes J; Issa N; Dupuis A; Accoceberry I; Pedeboscq S
Infection; 2022 Aug; 50(4):995-1000. PubMed ID: 35274281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]